BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33636567)

  • 1. Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia.
    Awada H; Durmaz A; Gurnari C; Kishtagari A; Zawit M; Pagliuca S; Visconte V
    Blood Cells Mol Dis; 2021 May; 88():102549. PubMed ID: 33636567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience.
    Toogeh G; Ramzi M; Faranoush M; Amirizadeh N; Haghpanah S; Moghadam M; Cohan N
    Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e21-6. PubMed ID: 26725263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
    Zidan MA; Kamal Shaaban HM; Elghannam DM
    Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Naoe T
    Leuk Res; 2011 May; 35(5):685-8. PubMed ID: 21256590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
    Niavarani A; Horswell S; Sadri R; Bonnet D
    Ann Hematol; 2016 Jan; 95(2):179-90. PubMed ID: 26499507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
    Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG
    Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
    Yamauchi T; Negoro E; Lee S; Takai M; Matsuda Y; Takagi K; Kishi S; Tai K; Hosono N; Tasaki T; Ikegaya S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Anticancer Res; 2013 Aug; 33(8):3335-40. PubMed ID: 23898100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
    Hollink IH; van den Heuvel-Eibrink MM; Zimmermann M; Balgobind BV; Arentsen-Peters ST; Alders M; Willasch A; Kaspers GJ; Trka J; Baruchel A; de Graaf SS; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
    Blood; 2009 Jun; 113(23):5951-60. PubMed ID: 19171881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
    Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 mutations and polymorphisms in Southeast Asian acute myeloid leukemia.
    Lauhakirti D; Sritana N; Boonthimat C; Promsuwicha O; Auewarakul CU
    Exp Mol Pathol; 2011 Dec; 91(3):682-6. PubMed ID: 21798259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system.
    Hou HA; Huang TC; Lin LI; Liu CY; Chen CY; Chou WC; Tang JL; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Blood; 2010 Jun; 115(25):5222-31. PubMed ID: 20368469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
    Becker H; Maharry K; Radmacher MD; Mrózek K; Metzeler KH; Whitman SP; Schwind S; Kohlschmidt J; Wu YZ; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Moore JO; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
    Haematologica; 2011 Oct; 96(10):1488-95. PubMed ID: 21659357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
    Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
    Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse.
    Mashima K; Oh I; Ikeda T; Toda Y; Ito S; Umino K; Minakata D; Nakano H; Morita K; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Fujiwara SI; Hatano K; Sato K; Omine K; Muroi K; Kanda Y
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e521-e527. PubMed ID: 30181104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group.
    Sano H; Shimada A; Tabuchi K; Taki T; Murata C; Park MJ; Ohki K; Sotomatsu M; Adachi S; Tawa A; Kobayashi R; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y
    Int J Hematol; 2013 Oct; 98(4):437-45. PubMed ID: 23979985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database.
    Xu J; Zhang Y; Hu J; Ren Y; Wang H
    Hematology; 2020 Dec; 25(1):79-84. PubMed ID: 32019476
    [No Abstract]   [Full Text] [Related]  

  • 18. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
    Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis.
    Long J; Fang S; Dai Q; Liu X; Zhu W; Wang S
    Oncotarget; 2016 May; 7(22):32079-87. PubMed ID: 26992216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia.
    Choi Y; Lee JH; Hur EH; Kang MJ; Kim SD; Lee JH; Kim DY; Lim SN; Bae KS; Lim HS; Seol M; Kang YA; Lee KH
    Ann Hematol; 2012 May; 91(5):671-677. PubMed ID: 22015946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.